INTRODUCTION
Nigella sativa is an annual flowering plant, which is native to India and Pakistan and commonly used as a spice. The oil obtained from the seeds of this plant has traditionally used for the treatment of arthritis, pulmonary disease and hy-
ABSTRACT
The aim of the current study is to develop solid, semisolid or liquid form of radionuclide labeled thymoquinone glucuronide conjugated magnetite nanoparticles those targets to the tumor for diagnosis and therapy of cancer.
For this purpose, thymoquinone (TQ), a molecule present in the seeds of Nigella (Nigella sativa) used to enhance the affinity of the drug to the tumor cells. TQ was isolated from its microsomes and an enzymatic method applied to synthesize beta glucuronic acid derivatized thymoquinone glucuronide (TQG). TQG attached magnetic nanoparticles (TQG-Fe 3 O 4 ). TQG-Fe 3 O 4 were radiolabeled with 125 
I and (
125 percholesterolemia, especially in Arabian culture. Biological activity of Nigella seeds originates from thymoquinone derivatives, which is dominant (30-48%) compound of volatile oil content 29 . A limited number of clinical trials show that, there is no side effects of thymoquinone on human, even at high dosages of this compound. Therefore, it is highly desirable to form a novel compound, which is hydrolyzed in tumor by beta-glucuronidase with glucuronic acid conjugation of thymoquinone.
It is well-known that, some cancer cells are very rich for beta glucuronidase. Information is available about lung cancer cells have high beta glucuronidase activity 20 .
Labeling glucuronide derivatives with technetium-99m ( 99m Tc) or radioiodine with the advantage of higher expression of beta glucuronidase enzymes in tumor tissues rather than normal tissues, have been studied by our group for more than a decade 1, 2, 4, 5, [8] [9] [10] [11] 13, 15, 16, 21, [23] [24] [25] [26] [27] 29, 30 . Stachulski and Meng reported that glucuronide derivatives of the cytotoxic molecules used in the cancer therapy are significantly reducing the use of glucuronide derivative molecule increased day by day 22 .Different studies uracil-O-glucuronide are showing that affinity of this molecule in cancer cells is significantly higher than normal cells. For example, production of uracil-O-glucuronide (UOG) significantly increased in HuTu 80 small bowel cancer cells in comparison with normal human intestinal epithelial cells 6 . Beta-glucuronidase is present in higher levels than in normal tissue, also led this enzyme in tumor tissue to be more active in more acidic environments such as the and relatively easy to measure to some cytotoxic molecules glucuronide derivative of the birth of the idea that can be a good anticancer agents 3 . Nanoparticles with magnetic properties can be used in imaging, diagnosis and treatment of various diseases and to separate of biological materials. Patient-related, magnetic controlled drug targeting system is reported by Lubbe et Tc is the only thymoquinone derivative that be usable over gamma scintigraphy 17 .
The aim of current study is as follows:
• Synthesis of a thymoquinone glucuronide derivative,
• Conjugation with magnetic nanoparticles (Fe 3 O 4 , nm size),
• Radiolabeling with 125 I and also other iodine radioisotopes,
• Development of formulations of generated solid radiolabeled nanoparticles showing the magnetic properties in solid, semi-solid and liquid forms.
• Determination of in vitro affinity by using Human lung adenocarcinoma cells (A549) and normal human lung epithelial cells (BEAS-2B).
MATERIAL METHOD

Materials
Na
125
I is obtained from the Institute of Isotopes Co. Ltd., Budapest.BEAS-2B and A549 cell lines were obtained from American Type Culture Collection, Rockville, MD, USA and Bio-engineering Department of Ege University, Izmir, Turkey, respectively. WST-8 assay, iodogen (1,3,4,6-tetrachloro-3α,6 α-diphenylglycouril), ferrous chloride (FeCl 3 ) and ferric chloride tetrahydrate (FeCl 2 .4H 2 O) were purchased from Sigma-Aldrich. All other chemicals purchased from Merck and Lonza. All solvents were reagent grade and, are used without further purification.
Equipment
Transmission electron microscopy (TEM, JEOM JEM 2100F HRTEM), X-ray diffraction (XRD, Philips X'Pert Pro), dynamic light scattering (DLS) (Malvern Nano-ZS) were used for characterization of synthesized Fe 3 O 4 nanoparticles. Bioscan AR-2000 Imaging Scanner and Packard Tri-Carb-1200 Liquid Scintillation Spectrometer used for Thin Layer Radio Chromatography (TLRC) method and incorporation studies, respectively.
Glucuronidation of Thymoquinone (TQ)
Obtaining of UDP-glucuronyl transferases enzyme (UDPGT) from A549 Cells
Microsome preparates separated from human lung carcinoma cells (A549) used as a UDP-glucuronyl transferase (UDPGT) source, which is required for glucuronidation of thymoquinone. A549 cells were grown in MEM supplemented with 10 % FBS, 2.0 mM glutamine, 0.1 mM nonessential amino acid, 1,5 g/L sodium bicarbonate and 1 mM sodium pyruvate. Mediums removed and cells washed 3 times with PBS. Cells were detached from the surface and cell pellets washed with sucrose/hepes 3 times with centrifugation (4 ºC, 1000 rpm and 10 min) in every step. Then cells ruptured with homogenizator for 4 minutes at ice bath. Homogenate was centrifuged at 4 ºC, 10500 rpm for 10 minutes and supernatant was centrifuged at 4 ºC, 28000 rpm for 10 minutes by ultracentrifuge. After centrifugation supernatant was removed and enzymes were solubilized with pH 7 buffer (0.2 M potassium phosphate, 2 mM mercaptoethanol and 0.4% Triton X100) and stirred for 30 min. at 4 ºC. Solubilized enzymes were centrifuged at 4 ºC, 28000 rpm for 10 minutes. Protein concentration of the supernatant, which contains microsomal samples determined with bicinchoninic acid method using Thermo Varioskan Flash multimode microplate reader. Absorbance reading was performed at 260 nm and protein concentration was obtained as 3.44 mg/mL.
Enzymatic Synthesis of Thymoquinone Glucuronide (TQG)
34.4 mg microsomal enzyme in 5 mL of 50 mM Tris Buffer (pH = 8) which contains 6 mM CaCl 2 , 10 mM UDPGA and 1 mM DTT were stirred at 37 ºC for 10 min in a water bath. Then thymoquinone in 10 mg/mL of DMSO was added and incubated at the same temperature for 18 hours. After incubation acetonitrile (300 µL) was added to the solution and centrifuged at 2000 rpm for 20 min. Purity analysis of product was conducted by HPLC (Schimadzu LC10 ATVP).
Preparation of Magnetic Nanoparticle Conjugated TQ and TQG
Synthesis of Magnetic (Fe 3 O 4 ) Nanoparticles
One hundred mL of ferrous salt solution in acidic environment was prepared using 2 M FeCl 3 (12 mL) and 2 M HCl, Then, 0.08 M Na 2 SO 3 (50 mL) was added slowly under nitrogen gas. Ammonia (NH 3 ) (25%, 8 mL) was added to the mixture under nitrogen gas. The mixture waited at 70 °C for 15-30 minutes. Then the temperature of the mixture was cooled under 45° C. Black colored particles were collected with a magnet and washed with ethanol for 3 times. Particles were stored in ethanol at 4° C.
Coating of Fe 3 O 4 Nanoparticles with Silica
Five mL tetra ethyl ortho silicate (TEOS) and NH 3 (10%, 5 mL) was added into the magnetic particle solution. The reaction was carried under at 40°C for 12 hours under magnetic stirring and was washed with methanol 3 times.
Amino Silane Conjugation of Silica Coated Fe 3 O 4 Nanoparticles
Amino silane agent [N-(2-aminoetil) -3-aminopropil-trimetoksisilan] was added into the magnetic nanoparticles in ethanol and solution was kept in an ultrasonic bath for 5 minutes. After uniform dispersing, the reaction was carried out at 60 °C for 12 minutes and washed with ethanol 3 times. The resulting precipitates were collected, dried under vacuum and stored at 4°C.
Immobilization of TQ and TQG to Fe 3 O 4 Nanoparticles (TQ-Fe 3 O 4 and TQG-Fe 3 O 4 )
Twenty-five mg/mL of silanized 
Inactive iodination of TQG [Inactive iodine (127I) labeled TQG (127I-TQG)]
Cold-iodination of TQG was performed to gain insight about the molecular structure of radioiodinated TQG. With this purpose, TQG was iodinated within active iodine ( 127 I) by using stoichiometrically equivalent amounts of potassium iodide and oxidizing agent iodogen to prove the identity of the radiolabeled compound.
Quality Control Studies of TQ and TQG by using High Performance Liquid Chromatography (HPLC)
TQ and enzymatically glucuronidated TQG were analyzed with HPLC. A lowpressure gradient HPLC system (LC-10ATvp quaternary pump, SPD-M20A DAD detector, a syringe injector equipped with a 500 lL loop, CTO-10AS column oven, SIL 20A-HT auto sampler, FRC-10A fraction collector and 5µ C18-ODS column (250 x 4.6 mm ID) was used for HPLC analysis.1mL/min was flow rate of the mobile phase and readings were collected at 254 nm. Mobile phase of analysis was water/methanol/isopropanol (50:45:5). HPLC chromatogram of TQ and TQG was shown in Figure 1 . I-TQG, and also with other fragments were given in Table 1 . (Figure 2) . 
Quality control studies of radiolabeling compounds
The thin layer radio chromatography (TLRC) was used to determine the radiolabeling compounds ( 10 cm × 1.5 cm sized cellulose TLC strips were used as stable phase and 4 developing baths were used as mobile phase. The content of the developing baths is: n-butanol / bidistiled water / acetic acid (4:2:1) (TLRC1), n-butanol / ethyl alcohol / 0.2 N NH 4 OH (5:2:1) (TLRC2), isopropanol / n-butanol / 0.2 N NH 4 OH (4:2:1) (TLRC3) and isopropanol / n-butanol / 0.2 N NH 4 OH (2:1:1) (TLRC4). Two µL of radio ligand was applied to Thin Layer Chromatography (TLC) strips and placed to the solutions. After mobile phase reached the end-point, TLC strips were removed from bath solutions and left to dry. Radiochromatograms of TLC strips were obtained by Bioscan AR2000 TLRC scanner. R f values of radiolabeled compounds and radiolabeling yields were calculated. Because of the higher separation efficiency TLRC1 developing bath was used in determining radiolabeling yield. R f values of radioactive components were given in Table 2 . Cellulose TLC strips, n-butanol / bidistilled water / acetic acid (4:2:1) (TLRC 1)
Cell Culture Studies
Human lung adenocarcinoma cells (A549) were grown in MEM supplemented with 10 % FBS, 2.0 mM glutamine, 0.1 mM nonessential amino acid, 1.5 g/L sodium bicarbonate and 1 mM sodium pyruvate and; normal human lung epithelial cells (BEAS-2B) were grown in Clonetics BEGM BulletKit. All cells were grown at 37 °C in a humidified incubator equilibrated with 5.0% CO 2 . The cells were maintained in exponential growth by sub-culturing with trypsin-EDTA (0.25% by w/v in Hank's balanced salt solution). The cells were then pelleted and resuspended in cell medium. In cell culture studies, samples that are conjugated to magnetic nanoparticles were exposed to a constant magnetic field (1.17-1.21 Tesla) while studies. Control and other nonmagnetic samples were not treated with the external magnetic field. 
Cytotoxicity Studies
Apoptosis Study
Apoptotic effects of samples were evaluated on A549 and BEAS-2B cells by using the Dead Ende Fluoro-metric TUNEL System (Promega) accordin g to the manufacturer's instructions as described below. Minimum 300 cells were evaluated for each group. Cells were prepared on chamber slides. After 24 hours, mediums of cells were changed with mediums, which contain samples in IC 50 concentrations. After 24 hours, medium of chamber slides was removed and washed with PBS 2 times. Slides with cells were incubated in PBS with paraformaldehyde (4%) (pH 7.4) solution at 4°C, for 25 minutes. Then the slides were incubated in PBS with Triton-X (0.2%) for 5 minutes to increase the cell permeability. Then the slides were washed with PBS 3 times for 5 minutes. One hundred µL of equilibration tampon was added to the slides and incubated for 10 minutes. During this time, rTdT incubation tampon was prepared: 90 µL equilibration tampon, 10 µL nucleotide mixture and 2 µL rTdT enzyme. After 5-10 minutes, liquid in the slides were removed and nucleotide mixture was added instead of this, then lamella was used. Samples were incubated at 37°C for 60 minutes. At room temperature, samples were incubated in 2XSSC for 15 minutes to stop the reaction. The slides were washed with PBS for 5 minutes and this process was repeated 3 times. The slides were incubated in propidium iodid solution (1 µg/mL) for 15 minutes. After the slides were dried, the cells were imaged by fluorescence microscope by using green (520 nm) and red (620 nm) filters.
Time Dependent Incorporation Study of
I Labeled Samples on Cells
Cells were grown to determine the optimum time parameter for incorporation of 
Statistical analysis
The statistical significance of cell culture studies was assessed by one-way ANO-VA and linear regression using the Graph Pad (prism 2.01V) program. Probability values P < 0.05 were considered statistically significant for studies. Table 1 Figure 1 is examined, it is seen that there is an aggregation between nanoparticles and size of nanoparticles is ranging between 7.63-26.95 nm. Also, the resulting nanoparticles were found to be spherical in shape.
RESULTS AND DISCUSSION
Structural Analysis Studies of TQG and
127
I-TQG Compounds
TEM: When
EDX: As seen in Figure 1 , the amount of Fe, O and Si are compatible with the elemental structure according to EDX results of silane conjugated Fe 3 O 4 nanoparticles. The results are appropriate with expected structure.
Quality Control Studies by Chromatographic Methods
High Performance Liquid Chromatography (HPLC):
Retention time (R t ) values of some compounds are given in Figure 2 , R t value of TQ is determined as 2.65 min. while TQG's is 33.35 min R t value.
This result shows that the reaction of glucuronidation was performed with yield of 69.16±3.28 % (n=3). R t values of radiolabeled compounds are given in Table 3 . 
Comparison of Incorporation Efficiency between A-549 and BEAS-2B cells
Comparison of incorporation efficiency of 125 I labeled samples on BEAS-2B and A549 cells is shown in Figure 4 . After 2 hours, 
Time Dependent Incorporation Study
Results of time dependent incorporation study of 125 I labeled samples on A549 cells are given in Figure 6 . Incorporation ratios of all samples increased by the time and the highest amount is determined for Fe 3 O 4 conjugated TQG. The magnetic field has a dramatic effect on the incorporation ratios with the compounds loaded onto magnetic nanoparticles. Results show that magnetic nanoparticles could be used as efficient carriers for the bioactive molecules along with drugs, and these nanoparticles might be easily accommodated to the targeted for diagnosis and therapy applications 16 . 
CONCLUSION
